Napa Therapeutics Company
Napa Therapeutics is a biotechnology company focused on a novel target linked to one of the fundamental processes of aging. A privately held British Virgin Islands company with an office in the Isle of Man, Napa is developing small molecule drugs to address this target. Napa Therapeutics is a spinout from The Buck Institute for Research on Aging partnering with Juvenescence.
Industry:
Small&Large Molecules
Headquarters:
Los Angeles, California, United States
Founded Date:
2018
Employees Number:
1001-5000
Last Funding Date:
2018
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership